Finance entity
All 1 tracked stories fall under one category: earnings. Charles Schwab is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 2 original sources per story, versus 2.6 across the same-window beat baseline.
Last mentioned: Mar 25, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: earnings. Charles Schwab is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 2 original sources per story, versus 2.6 across the same-window beat baseline. Their average consequence score of 7 runs above the beat's 6.3 for that window. Maher Masoud appears in 1 tracked Finance story from March 25, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 84 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Maher Masoud. Shared-story counts are live from our verified record — not editorial picks.
Charles Schwab reported record-breaking 2025 results with $12 trillion in client assets and a 50% surge in adjusted EPS, signaling a powerful recovery in the brokerage sector. Conversely, life sciences firm MaxCyte is navigating a 15% revenue decline as cell therapy customers consolidate programs and reduce capital expenditures.
Maher Masoud is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
